S-Ruxolitinib,
941685-37-6,
S-Ruxolitinib (INCB018424),
Ruxolitinib S enantiomer,
Ruxolitinib (S enantiomer),
(R)-ruxolitinib,
(3s)-3-cyclopentyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]propanenitrile,
INCB-18424,
INCB 18424,
(S)-Ruxolitinib,
PubChem19323,
SCHEMBL99225,
CHEMBL1287854,
DTXSID30678918,
BCP15524,
2727AH,
HY-50856A,
s2902,
ZINC63539381,
AKOS005145906,
CS-2768,
BC638774,
SW220207-1,
I14-16747,
(S)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile,
(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (ent-Ruxolitinib),
1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (betaS)-,
Ruxolitinib,
INCB018424,
Ruxolitinib (INCB018424),
C17H18N6,
A4149,
941678-49-5,